Loading…

Multicentre interlaboratory analysis of routine susceptibility testing with a challenge panel of resistant strains

•Quality control should include organisms with relevant and emerging resistances.•A challenge panel of 12 multidrug-resistant organisms was tested by nine laboratories.•Overall categorical agreement was >90% for all but one strain.•Higher discrepancies were observed for fosfomycin, meropenem, azt...

Full description

Saved in:
Bibliographic Details
Published in:Journal of global antimicrobial resistance. 2022-03, Vol.28, p.125-129
Main Authors: Deckers, Corentin, Soleimani, Reza, Denis, Olivier, Bogaerts, Pierre, Berhin, Catherine, Rodríguez-Villalobos, Hector, Descy, Julie, Hallin, Marie, Nonhoff, Claire, Desmet, Stefanie, Magerman, Koen, Van den Abeele, Anne Marie, Lissoir, Bénédicte, Matheeussen, Veerle, Vernelen, Kris, Huang, Te-Din
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Quality control should include organisms with relevant and emerging resistances.•A challenge panel of 12 multidrug-resistant organisms was tested by nine laboratories.•Overall categorical agreement was >90% for all but one strain.•Higher discrepancies were observed for fosfomycin, meropenem, aztreonam and tigecycline. In order to elaborate a new national challenge panel of resistant Gram-negative bacilli and Gram-positive cocci strains for the validation of routine antimicrobial susceptibility testing (AST) methods, an interlaboratory evaluation was organised. The results of 12 well-characterised multidrug-resistant strains tested by nine laboratories using local disk diffusion (DD) and automated AST (AUST) methods were compared with the reference broth microdilution method. Overall categorical agreement ranged from 70% to 100% both for DD and AUST and was >90% for all but one strain for all antibiotics. Our multicentre AST study showed good reproducibility and the panel can be used as national resistant reference strains for routine AST validation.
ISSN:2213-7165
2213-7173
DOI:10.1016/j.jgar.2021.12.020